Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients
This study has been completed.
Study NCT00220766.   Last updated on September 27, 2007.
Information provided by Talecris Biotherapeutics
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Immunologic Deficiency Syndrome
Agammaglobulinemia
Severe Combined Immunodeficiency
Wiskott-Aldrich Syndrome
Common Variable Immunodeficiency
Additional conditions recognized in this trial
Immunologic Deficiency Syndromes
Syndrome
More general conditions related to this trial
Blood Coagulation Disorders
Blood Coagulation Disorders, Inherited
Blood Platelet Disorders
Blood Protein Disorders
Disease
DNA Repair-Deficiency Disorders
Genetic Diseases, Inborn
Genetic Diseases, X-Linked
Hematologic Diseases
Hemorrhagic Disorders
Immune System Diseases
Infant, Newborn, Diseases
Lymphatic Diseases
Lymphoproliferative Disorders
Metabolic Diseases
Pathologic Processes
Purpura, Thrombocytopenic
Thrombocytopenia
Interventions listed in this trial
Dextrose, 5% in Water
Additional drug interventions recognized in this trial
Antibodies
Immunoglobulins
Immunoglobulins, Intravenous
Rho(D) Immune Globulin
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Talecris Biotherapeutics


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services